With significant amounts of risk capital now available through government programs and the recently enacted stimulus package, it is critical for the entrepreneur to understand how best to access it. Hear from Washington insiders on how to successfully access these programs and obtain capital from a variety of government agencies, including the DOE, USDA, DOD, SBIR and more.
Moderator: Joseph L. Colaneri
Panelists:
June Chocheles, President, Chocheles Consulting Group, LLC
Tyler Orion, Chair, CONNECT Foundation
Danielle Peters, Consultant, Fabiani & Company
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.